Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A

被引:47
|
作者
Shi, Rongxing [1 ]
Jiao, Zichen [1 ,2 ]
Yu, Ao [1 ]
Wang, Tao [1 ,2 ]
机构
[1] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China
关键词
FAM83A; FAM83A-AS1; long noncoding RNA; natural antisense transcripts; non-small-cell lung cancer; TKI RESISTANCE;
D O I
10.1002/jcb.28336
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The abnormal expression of long noncoding RNAs (lncRNAs) is closely associated with human cancers. As one special group of lncRNAs, natural antisense transcripts (NATs) can be transcribed from both DNA strands at the same locus but in the opposite direction from the gene transcript. Their expression levels are altered in many cancers, but their roles are poorly understood. We strove to find NATs involved in human non-small-cell lung cancer (NSCLC) and to reveal their mechanism of action in cancer. We analysed the NATs in NSCLC from the TCGA database by circlncRNAnet. One NAT, family with sequence similarity 83 member A antisense RNA 1 (FAM83A-AS1), was found to be markedly upregulated and positively correlated with its cognate sense counterpart, FAM83A, in NSCLC. Moreover, overexpression of FAM83A-AS1 increased FAM38A protein levels and induced ERK1/2 phosphorylation downstream of FAM83A in cells. Finally, overexpression of FAM83A-AS1 promoted LUAD cell proliferation and invasion. In summary, lncRNA FAM83A-AS1 promotes LUAD by increasing FAM83A expression.
引用
收藏
页码:10505 / 10512
页数:8
相关论文
共 50 条
  • [1] LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A
    Wang, Wenyi
    Zhao, Zhunlin
    Xu, Chun
    Li, Chang
    Ding, Cheng
    Chen, Jun
    Chen, Tengfei
    Zhao, Jun
    THORACIC CANCER, 2021, 12 (10) : 1495 - 1502
  • [2] FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
    Wang, Gaoming
    Li, Xiaokun
    Yao, Yu
    Jiang, Zhisheng
    Zhou, Hai
    Xie, Kai
    Luo, Jing
    Shen, Yi
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [3] Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
    He, Jinyu
    Yu, Jiao
    BIOSCIENCE REPORTS, 2019, 39
  • [4] FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKalpha signaling in lung adenocarcinoma
    Zhao, Huijie
    Wang, Yinghan
    Wu, Xing
    Zeng, Xaofei
    Lin, Baoyue
    Hu, Shengmin
    Zhang, Shenglin
    Li, Yu
    Zhou, Zhiqing
    Zhou, Yujie
    Du, Changzheng
    Beer, David G.
    Bai, Shengbin
    Chen, Guoan
    BIOENGINEERED, 2022, 13 (05) : 13312 - 13327
  • [5] Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression
    Huang, Hongyu
    Yang, Chuyi
    Zhang, Qichen
    Zhuo, Ting
    Li, Xiaohong
    Li, Nijiao
    Zhu, Lu
    Luo, Chenyang
    Gan, Jinyan
    Wu, Yanbin
    BIOENGINEERED, 2022, 13 (03) : 4964 - 4977
  • [6] Function of Antisense LncRNA RP11-539E17.5 and FAM83A-AS1 Up-Regulating FAM83A in Lung Adenocarcinoma Tumorigenesis and Development
    Wang, X.
    Wang, W.
    Meng, Y.
    Zhou, S.
    Kong, F.
    Yang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S424 - S424
  • [7] Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, PI3K, EMT pathways and tumor progression
    Zhao, Chenshu
    Li, Xiaowen
    Zhang, Rui
    Lyu, Hao
    Xiao, Shuai
    Guo, Dong
    Ali, Declan William
    Michalak, Marek
    Chen, Xing-Zhen
    Zhou, Cefan
    Tang, Jingfeng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [8] FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis
    Zheng, Yi-Wen
    Li, Zhi-Han
    Lei, Lei
    Liu, Chen-Chen
    Wang, Zhao
    Fei, Liang-Ru
    Yang, Mai-Qing
    Huang, Wen-Jing
    Xu, Hong-Tao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
    Bartel, Courtney A.
    Jackson, Mark W.
    PLOS ONE, 2017, 12 (05):
  • [10] FAM83A is a potential biomarker for breast cancer initiation
    Natascia Marino
    Rana German
    Ram Podicheti
    Pam Rockey
    George E. Sandusky
    Constance J. Temm
    Harikrishna Nakshatri
    Rebekah J. Addison
    Bryce Selman
    Sandra K. Althouse
    Anna Maria V. Storniolo
    Biomarker Research, 10